Skip Navigation



Human Molecular Genetics Advance Access published online on March 16, 2005

Human Molecular Genetics, doi:10.1093/hmg/ddi121
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
14/8/1087    most recent
ddi121v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Pedrola, L.
Right arrow Articles by Palau, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pedrola, L.
Right arrow Articles by Palau, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved

Article

GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria

Laia Pedrola 1, Antonio Espert 1, Xingyao Wu 2, Reyes Claramunt 1, Michael E. Shy 2, and Francesc Palau 1*

1 Laboratory of Genetics and Molecular Medicine, Department of Genomics and Proteomics, Instituto de Biomedicina, CSIC, Valencia, Spain
2 Department of Neurology and Centre for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI, USA

* To whom correspondence should be addressed.
Francesc Palau, E-mail: fpalau{at}ibv.csic.es


   Abstract

Mutations in GDAP1, the ganglioside-induced differentiation-associated protein 1 gene, cause Charcot-Marie-Tooth (CMT) type 4A, a severe autosomal recessive form of neuropathy associated with either demyelinating or axonal phenotypes. Here we demonstrate that GDAP1 has far greater expression in neurons than in myelinating Schwann cells. We investigated cell localization of GDAP1 by means of transient overexpression and co-localization with organelle markers in COS-7 cells, and by Western blot analysis of subcell fractions with anti-GDAP1 polyclonal antibodies in a human neuroblastoma cell line. We observed that GDAP1 is localized in mitochondria. We also show that C-terminal transmembrane domains are necessary for the correct localization in mitochondria; however, missense mutations do not change the mitochondrial pattern of the wild-type protein. Our findings suggest that CMT4A disease is in fact a mitochondrial neuropathy mainly involving axons, and represents a disease belonging to the new category of mitochondrial disorders caused by mutations in nuclear genes. We postulate that GDAP1 may be related with the maintenance of the mitochondrial network.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M M Reilly and M E Shy
Diagnosis and new treatments in genetic neuropathies
J. Neurol. Neurosurg. Psychiatry, December 1, 2009; 80(12): 1304 - 1314.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
V. Lupo, M. I. Galindo, D. Martinez-Rubio, T. Sevilla, J. J. Vilchez, F. Palau, and C. Espinos
Missense mutations in the SH3TC2 protein causing Charcot-Marie-Tooth disease type 4C affect its localization in the plasma membrane and endocytic pathway
Hum. Mol. Genet., December 1, 2009; 18(23): 4603 - 4614.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. Liesa, M. Palacin, and A. Zorzano
Mitochondrial Dynamics in Mammalian Health and Disease
Physiol Rev, July 1, 2009; 89(3): 799 - 845.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
T. Sevilla, T. Jaijo, D. Nauffal, D. Collado, M. J. Chumillas, J. J. Vilchez, N. Muelas, L. Bataller, R. Domenech, C. Espinos, et al.
Vocal cord paresis and diaphragmatic dysfunction are severe and frequent symptoms of GDAP1-associated neuropathy
Brain, November 1, 2008; 131(11): 3051 - 3061.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
D.-F. Suen, K. L. Norris, and R. J. Youle
Mitochondrial dynamics and apoptosis
Genes & Dev., June 15, 2008; 22(12): 1577 - 1590.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
V. J. Davies, K. A. Powell, K. E. White, W. Yip, V. Hogan, A. J. Hollins, J. R. Davies, M. Piechota, D. G. Brownstein, S. J. Moat, et al.
A missense mutation in the murine Opa3 gene models human Costeff syndrome
Brain, February 1, 2008; 131(2): 368 - 380.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
A. Niemann, M. Ruegg, V. La Padula, A. Schenone, and U. Suter
Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease
J. Cell Biol., September 26, 2005; 170(7): 1067 - 1078.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Bolis, S. Coviello, S. Bussini, G. Dina, C. Pardini, S. C. Previtali, M. Malaguti, P. Morana, U. Del Carro, M. L. Feltri, et al.
Loss of Mtmr2 Phosphatase in Schwann Cells But Not in Motor Neurons Causes Charcot-Marie-Tooth Type 4B1 Neuropathy with Myelin Outfoldings
J. Neurosci., September 14, 2005; 25(37): 8567 - 8577.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.